Head-to-head clinical analysis & difference comparison: details on mechanism of action, dosing, half-life, interactions, and maternal-fetal safety.
STERILE WATER IN PLASTIC CONTAINER vs PHOXILLUM B22K 4/0 IN PLASTIC CONTAINER
Clinician-reviewed, head-to-head comparison of mechanism, dosing, pharmacokinetics, and safety profiles.
Last clinically reviewed: July 2026 · OpiCalc Medical Review Team
Sterile water serves as a diluent or solvent for parenteral administration; no pharmacological activity.
PHOXILLUM B22K 4/0 is a peritoneal dialysis solution containing bicarbonate/lactate as buffer. It corrects electrolyte imbalances, removes waste products (e.g., urea, creatinine) via diffusion and ultrafiltration across the peritoneal membrane. Bicarbonate helps correct metabolic acidosis.
Diluent for reconstitution of medications,Irrigation during surgical procedures,Maintenance of fluid balance when administered with electrolytes
Peritoneal dialysis for patients with end-stage renal disease,Correction of fluid and electrolyte imbalances,Correction of metabolic acidosis
Not applicable; Sterile Water is used as a vehicle for reconstitution or dilution of compatible medications per manufacturer guidelines, not as a therapeutic agent with intrinsic dosing.
Intravenous infusion of 4 mmol/kg potassium phosphate per 24 hours, administered at a rate not exceeding 10 mmol/hour as part of total parenteral nutrition; typical adult dose: 30-40 mmol potassium phosphate per day.
Terminal elimination half-life of free water is approximately 9–10 minutes in normal renal function, reflecting rapid redistribution and elimination; prolonged in renal impairment.
Terminal elimination half-life is approximately 0.5–1 hour in patients with normal renal function. In end-stage renal disease (ESRD), half-life extends to 6–8 hours, requiring dose adjustment.
Non-metabolized; renally excreted unchanged.
Bicarbonate and lactate are metabolized in the liver and kidneys. Lactate is converted to bicarbonate via hepatic gluconeogenesis and the Cori cycle.
Water is eliminated primarily via the kidneys. Renal excretion accounts for >99% of administered water, with a small fraction lost through insensible routes (e.g., skin, lungs).
Renal: 100% (proximal tubular secretion and glomerular filtration). Biliary/fecal: negligible (<1%).
Water does not bind to plasma proteins; effectively 0% bound.
Approximately 10–20% bound to albumin. Binding is low and clinically insignificant.
Volume of distribution approximates total body water: ~0.55–0.75 L/kg in adults; higher in neonates and patients with edema.
Volume of distribution is 0.2–0.3 L/kg (10–20 L in adults), approximating extracellular fluid volume. This small Vd is consistent with limited tissue penetration.
Intravenous: 100%.
Intravenous: 100% (only route of administration).
No adjustment required; Sterile Water does not undergo renal clearance and is not pharmacologically active.
Contraindicated in severe renal impairment (e GFR <30 m L/min/1.73m²) due to risk of hyperphosphatemia and hyperkalemia. In mild to moderate impairment (e GFR 30-89): reduce dose by 25-50% and monitor serum potassium and phosphate levels.
No adjustment required; Sterile Water is not metabolized by the liver and has no hepatic effects.
No specific dose adjustment recommended for Child-Pugh class A or B. For Child-Pugh class C: use with caution and consider reducing dose by 25% due to potential for altered phosphate metabolism and encephalopathy risk.
Use as a diluent or vehicle per specific medication instructions; no weight-based dosing for sterile water itself.
Dose based on body weight: 1-2 mmol/kg/day of potassium phosphate intravenously as part of parenteral nutrition, with infusion rate not exceeding 0.5 mmol/kg/hour. Maximum daily dose: 4 mmol/kg.
No specific considerations; use as directed for the reconstituted medication, monitoring fluid balance as clinically indicated.
Start at lower end of dosage range (e.g., 20-30 mmol/day) due to age-related renal function decline. Monitor renal function and serum electrolytes closely; adjust dose based on creatinine clearance.
None
None.
Risk of hemolysis if administered intravenously without electrolytes; use only as a diluent; not for direct intravascular injection unless isotonicity is achieved.
Peritonitis risk,Catheter-related infections,Fluid and electrolyte disturbances,Metabolic alkalosis (with high bicarbonate levels),Hypokalemia or hyperkalemia,Peritoneal membrane failure
None known for sterile water itself; contraindicated for direct intravenous administration without adjustment of tonicity.
Hypersensitivity to any component,Pre-existing severe metabolic alkalosis,Documented peritoneal membrane failure,Abdominal or peritoneal defects (e.g., hernias, fistulas),Uncorrected mechanical defects in peritoneal cavity
No known food interactions. Sterile water is not administered orally for hydration; intravenous hydration requires balanced electrolyte solutions.
No direct food interactions, but dietary intake of potassium, calcium, and phosphorus must be managed per clinical guidelines during CRRT. Avoid high-potassium foods (e.g., bananas, oranges, potatoes) unless potassium supplementation is adjusted accordingly.
No teratogenic risk; sterile water is a physiologic fluid with no known fetal toxicity across all trimesters.
No well-controlled studies in pregnant women. Animal reproduction studies not conducted. Potassium phosphate is essential for fetal development; however, hyperphosphatemia or electrolyte imbalances may pose risks. First trimester: theoretical risk of teratogenicity only with severe maternal hyperphosphatemia. Second/third trimesters: risks include fetal hyperphosphatemia, hypocalcemia, and potential soft tissue calcification. Use only if clearly needed.
Safe during breastfeeding; water is a normal constituent of breast milk. M/P ratio not applicable.
Potassium phosphate is present in human milk at levels consistent with physiological requirements. Milk-to-plasma ratio not established. Exogenous phosphate is rapidly absorbed and may cause hyperphosphatemia in the infant at high maternal doses. Caution advised; monitor infant for signs of hyperphosphatemia (e.g., hypocalcemia, tetany).
No dose adjustment required; pharmacokinetics of water are unchanged in pregnancy.
Physiologic increase in plasma volume and glomerular filtration rate in pregnancy may increase phosphate clearance, potentially requiring higher doses to maintain therapeutic levels. However, individualize dosing based on serum phosphate monitoring. No standard dose modification; adjust per clinical response and lab values.
Sterile water is used for irrigation, dilution, and reconstitution of medications; not for intravenous injection without adjusting tonicity to avoid hemolysis. Utilize single-dose containers to minimize contamination risk. Confirm sterile water is appropriate for the intended route; for wound irrigation, use sterile water for irrigation, not sterile water for injection.
PHOXILLUM B22K 4/0 is a bicarbonate-buffered, low-calcium dialysate for continuous renal replacement therapy (CRRT). Monitor serum potassium closely as it contains 4 m Eq/L K+, 0 m Eq/L Ca2+, and 22 m Eq/L bicarbonate. Use with caution in hyperkalemic patients; may require adjustment of potassium supplementation. Ensure adequate calcium replacement via separate infusion to avoid hypocalcemia. Verify compatibility with other IV fluids and medications administered through the CRRT circuit.
Do not inject sterile water directly into a vein as it can cause red blood cell destruction.,Use only as directed by a healthcare professional; do not use if the container seal is broken or damaged.,Do not save any unused portion for later use; discard any remaining solution after use.,This product is not intended for drinking; do not ingest.,Inform your healthcare provider if you have any allergies or medical conditions.
This solution is used only during continuous dialysis in the hospital setting; it is not for direct infusion into your vein.,Your healthcare team will monitor your blood potassium and calcium levels closely while you receive this treatment.,Do not eat or drink anything unless your doctor or nurse approves, as your diet may need to be adjusted.,Report any muscle cramps, tingling, or irregular heartbeat to your nurse immediately.
No interactions on record
No interactions on record
Explore head-to-head clinical comparisons of other medications in the same therapeutic classes.
Common clinical questions about STERILE WATER IN PLASTIC CONTAINER vs PHOXILLUM B22K 4/0 IN PLASTIC CONTAINER, answered by our medical review team.
STERILE WATER IN PLASTIC CONTAINER is a Irrigation Solution that works by Sterile water serves as a diluent or solvent for parenteral administration; no pharmacological activity.. PHOXILLUM B22K 4/0 IN PLASTIC CONTAINER is a Irrigation Solution that works by PHOXILLUM B22K 4/0 is a peritoneal dialysis solution containing bicarbonate/lactate as buffer. It corrects electrolyte imbalances, removes waste products (e.g., urea, creatinine) via diffusion and ultrafiltration across the peritoneal membrane. Bicarbonate helps correct metabolic acidosis.. They differ in pharmacokinetic profiles, FDA-approved indications, and side effect profiles.
Potency comparisons between STERILE WATER IN PLASTIC CONTAINER and PHOXILLUM B22K 4/0 IN PLASTIC CONTAINER depend on the specific clinical indication. These are both Irrigation Solution agents and are not directly interchangeable by dose. A physician or clinical pharmacist should guide any therapeutic switching decisions.
The standard adult dose of STERILE WATER IN PLASTIC CONTAINER is: Not applicable; Sterile Water is used as a vehicle for reconstitution or dilution of compatible medications per manufacturer guidelines, not as a therapeutic agent with intrinsic dosing.. The standard adult dose of PHOXILLUM B22K 4/0 IN PLASTIC CONTAINER is: Intravenous infusion of 4 mmol/kg potassium phosphate per 24 hours, administered at a rate not exceeding 10 mmol/hour as part of total parenteral nutrition; typical adult dose: 30-40 mmol potassium phosphate per day.. Dosing should always be individualized based on indication, renal and hepatic function, age, and other patient factors.
No direct drug-drug interaction has been formally documented between STERILE WATER IN PLASTIC CONTAINER and PHOXILLUM B22K 4/0 IN PLASTIC CONTAINER in current clinical databases. However, individual patient risk factors including other medications, organ function, and comorbidities should always be evaluated by a qualified healthcare provider.
The maternal-fetal safety profiles differ. STERILE WATER IN PLASTIC CONTAINER is classified as Category C. No teratogenic risk; sterile water is a physiologic fluid with no known fetal toxicity across all trimesters.. PHOXILLUM B22K 4/0 IN PLASTIC CONTAINER is classified as Category C. No well-controlled studies in pregnant women. Animal reproduction studies not conducted. Potassium phosphate is essential for fetal development; however, hyperphosphatemia or elect. Always consult a maternal-fetal medicine specialist before taking either drug during pregnancy or lactation.